baber/WOPTO huggingface dataset:
Patent RO-127252-A0 (RO)
Title: Process for the combined treatment of liquids
Inventor: HADAR ANTON
IPC: A01J7/00
Filed: 2011-11-23
Abstract: The invention relates to a process for the combined treatment of liquids containing molecular species, colloids or micro-organisms, which can be used for sterilizing liquids for medical and food-producing purposes, for treating water with a view to preventing colloidal deposits and corrosion, for the decontamination of waste water, for the bioactivation of liquids employed in irrigations and for producing emulsions or coalescence in liquid emulsions. According to the invention, the process comprises the combined treatment of liquids in ultrasound and electrostatic field, using the cavitation effect of ultrasounds, the action of the electrostatic field and the action of the centrifugal field providing for the ultra-compact filtration of the liquid containing molecular species, colloids or micro-organisms (A), ultrasound disaggregation and dispersion of the particles within the liquid, by combining the action of ultrasounds and the centrifugal force (B), followed by the electrostatic treatment of the liquid through the liquid circulation in an electrostatic field of variable intensity and the electric dispersion of the contained particles in the liquid flowing sense and against the gravity force, intense homogenization by creating electro-convection fluxes, followed by the intense ejection of liquid into a zone where centrifugal forces occur, causing the separation of the particles within the liquid (C), after which the liquid is subjected to the combined action of thermal energy, electrostatic energy and transmembrane pressure force (D), the particles within the treated liquid undergoing a chemical and biophysical transformation which leads to destruction of the colloidal species, degradation of chemical particles and membrane depolarization of micro-organisms with lethal effect thereupon.
Patent RO-133586-A0 (RO)
Title: Public warning systems based on weather parameters change for each microclimate
Inventor: CONŢ-STOICA ADRIAN
IPC: G08B25/10
Filed: 2018-11-05
Abstract: The invention relates to a system for public warning upon changes of weather parameters, meant for broadcasting weather alert messages and similar information for the community. According to the invention, the public warning system consists of a number of electronic display panels, where each such panel interacts with a GSM/GPRS/LTE communicator which receives data regarding the weather parameters, such as humidity, temperature, atmospheric pressure, from a weather station which is a component of the system, the power needed for operation being provided from a power supply source.
Patent RO-135295-A0 (RO)
Title: Multi-sensor system for estimation of tiredness, sleepiness and stress level, with applicability in critical infrastructures
Inventor: DUMITRESCU CĂTĂLIN
IPC: G06N20/00
Filed: 2021-06-24
Abstract: The invention relates to a multi-sensor system for estimation of tiredness, sleepiness and stress level, applicable in critical infrastructures. According to the invention, the system comprises a network of biomedical multi-sensors (EEG, ECG) and electro-optical sensors in the visible and kinetic spectrum for detection of cognitive states, and an information system for processing the information coming from the sensors and for computing, using a portable computer with graphic processors, where the ECG sensor is non-invasive and achieves remote acquisition of cardiological waves, based on the Doppler effect transmitted by an emitter in the range of microwaves with low emission power.
Patent MW-4786-A1 (MW)
Title: Interconnecting of low energy fuses
IPC: F42D1/06
Filed: 1986-06-16
Abstract: A connector 100 for interconnecting two lengths of low energy fuse 108, 110 includes connecting means 101 having a needle-like portion 102. The needle-like portion 102 is pointed at both ends 104, 106 to facilitate the penetration of the ends 104, 106 into the lengths of fuse 108 and 110 respectively. The connector 100 further includes a body 112 which defines seats 114 on which regions of the lengths of fuse 108, 110 can seat to be retained in position relative to the connecting means 101. End caps 116 are provided to clip into the body 112 to retain the lengths of fuse 108, 110 on the seats 114.
Patent IE-910272-A1 (IE)
Title: Preparation of anhydrous resorcinol-formaldehyde¹condensation products of low average molecular weight
IPC: C08G8/22
Filed: 1991-01-25
Abstract: Production of non-aqueous resorcin-formaldehyde condensation products with low average molecular weights containing no undesirable proportions of free resorcin by the acid-catalytic condensation of resorcin with formaldehyde or a formaldehyde derivative at high temperatures in an inert organic solvent with the azeotropic, distillative separation of the reaction water, whereby the reaction takes place in an apolar solvent which is not miscible with water in which resorcin dissolves readily but the resorcin-formaldehyde condensation product dissolves only with difficulty and is specifically heavier than the solvent or reactant solution so that two fluid phases ar formed, the lower of which consists of molten condensation product. The solvent is preferably fed back in the circuit from the water separator into the reactant solution through the lower phase and the condensation product is extracted from the lower phase. It may be freed of undesired resorcin contents by subsequent further solvent extraction. Use for condensation products as adhesion promoters in technical rubber articles containing steel or textile cords or for the production of waterproof wood glue and textile impregnants.
[DE4002417A1]
Patent MA-26858-A1 (MA)
Title: Acides ox(adi)azolyl-hydroxamiques utiles comme inhibiteurs de procollagene c-proteinase.
Inventor: SIMON BAILEY
IPC: A61P1/16
Filed: 2002-06-18
Abstract: DEPOSANT Sociétés dites : PFIZER INC. REVENDICATION DE PRIORITES GB 23/12/1999 9930570.8 Voir en annexe le titre de l'invention et le texte de l'abrégé "Acides  ox(adi)azolyl-hydroxamiques  utiles  comme inhibiteurs  de  procollagène  C-protéinase"  Les  composés  de   formule   (I  et leurs sels, produits de solvatation, précurseurs médicamenteux, etc., dans lesquels les substituants ont les significations indiquées dans le présent mémoire, sont des inhibiteurs de procollagène C-protéinase (PCP) et sont utiles dans des affections à médiation par la PCP.
Patent MA-28134-A1 (MA)
Title: Forme cristalline gamma du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent.
Inventor: HORVATH STEPHANE
Filed: 2006-02-13
Abstract: FORME CRISTALLINE (gama) DU CHLORHYDRATE DE L¿IVABRADINE, SON PROCEDE DE PREPARATION, ET LES COMPOSITIONS PHARMACEUTIQUES QUI LA CONTIENNENT Forme cristalline (gama) du chlorhydrate de l'ivabradine de formule (I) :  caractérisée par son diagramme de diffraction X sur poudre. Médicaments.
Patent MA-42750-A1 (MA)
Title: Smart windows comportant un film de dioxyde de vanadium dope par le tungstene
Inventor: EL KHATTABI EL MEHDI
IPC: C03C17/23
Filed: 2018-06-21
Abstract: Il s'agit d'une fenêtre recouverte d'un film de dioxyde de vanadium dopé par le tungstène (le pourcentage de dopage bien étudié en fonction des besoins de confort thermique intérieur et les condition météorologique), caractérisé par leur transition de phase, ce qui rend le coefficient de transmission élevé pour les basses températures et faible pour les hautes températures, cela conduit à l'optimisation du confort thermique de manière naturelle en été / hiver en diminuant la transmission du rayonnement solaire en été, et en l'augmentant en hiver.
Patent MA-54967-A1 (MA)
Title: Procédé de réparation ou d'amélioration de tubes absorbeurs avec perte d'isolation thermique de ou pour installations solaires thermiques
Inventor: CANCHO VERA JOSE CARLOS
IPC: F24S40/46
Filed: 2021-11-23
Abstract: L'invention concerne un procédé qu’il comprend la réalisation d'un trou (8) dans un support métallique (6) d'un tube absorbeur (1), la mise en communication fluidique d'une pompe à vide (7) avec la chambre (5) du tube absorbeur (1) au moyen du trou (s), actionner la pompe à vide (7) pour générer un vide dans la chambre (5) jusqu'à atteindre un seuil-de vide prédéterminé, et introduire un gaz inerte (22) à l'intérieur de.La chambre (5) et effectuer une pluralité de balayages avec ledit gaz inerte (22), évacuer l'hydrogène de la chambre (5), permettant ainsi de réduire ou d'éliminer j'accumulation d'hydrogène dans ladite chambre (5),de sorte qu'en conséquence, au moins une partie de la capacité d'absorption d' hydrogène du matériau getter est récupérée.
Patent UY-24609-A1 (UY)
Title: Procedimiento para la monoacilación de hidroxi taxanos
IPC: C07D305/14
Filed: 1997-07-07
Abstract: Procedimiento para la monoacilación selectiva de la desacetil-10 bacatina iii o de sus derivados en c-2 y c-4, que tienen agrupamientos hidroxilos libres en posiciones c-7 y c-10, caracterizado porque se efectúa la acilación de la 10-desacetilbacatina iii o de sus derivados en c-2 y c-4 por medio de una sal de metileno iminium.
Patent UY-24806-A1 (UY)
Title: Procedimiento para la preparación de composiciones farmacéuticas para la entrega sostenida de péptidos
Inventor: CHRISTOPHER J MOLINEAUX
IPC: C07K14/575
Filed: 1997-12-11
Abstract: Método de preparación de una composición farmacéutica consistente esencialmente en un complejo sólido iónico de un péptido farmacéuticamente activo y un portador macromolecular, que comprende combinar el portador y el péptido farmacéuticamente activo en una relación en peso de portador:péptido de 0,5:1 a 01,:1 bajo condiciones apropiadas para preparar una composición farmacéutica consistente esencialmente en un complejo sólido iónico de un péptido farmacéuticamente activo y un portador macromolecular, en la cual dicho complejo no es una microcápsula. Se incluye, por ejemplo un método según lo descrito, donde, el péptido es un análogo de la LHRH o de bradyquinina; o es un péptidomultivalente; así como donde el vehículo de macromolecular es un derivado aniónico de un polisacárido, polialcohol, carboxinmetil celulosa, entre otros. La composición es útil en el cáncer de próstata, de mama, de ovario, uterino y testicular, Hipertrofia prostática benigna, pubertad precoz, endometriosis y fibroma uterino.
Patent UY-27719-A1 (UY)
Title: Un derivado de piridina ópticamente activo y un medicamento que lo contiene.
Inventor: MURATA TOSHIKI
IPC: A47C21/00
Filed: 2003-03-12
Abstract: Una ( - ) -(2-(ciclopropilmetoxi) -6-hidroxifenil)-((3S)-3-piperidinil)-1,4-dihidro-2H-pirido(2,3-d)(1,3)oxazin-2ona ópticamente activa de fórmula o una sal del mismo. El compuesto tiene una excelente actividad antiinfalmatoria y otra actividad biológica.
Patent UY-29437-A1 (UY)
Title: Nuevos antagonistas de cgrp
Inventor: LUSTENBERGER PHILIPP
IPC: C07D401/14
Filed: 2006-03-22
Abstract: Son objeto de la presente invención nuevos antagonistas de CGRP de la fórmula general I en la que B, R1,y R2 están definidos como en la reivindicación 1, sus tautómeros, sus isómeros, sus diastereoisómeros, sus enantiómeros, sus hidratos, sus mezclas y sus sales, así como los hidratos de las sales, en especial sus sales fisiológicamente compatibles con ácidos inorgánicos u orgánicos o bases, medicamentos que contienen estos compuestos, su uso y procedimietos para su preparación.
Patent UY-29669-A1 (UY)
Title: Compuesto de 7-amino-6-triazolil-1,2,4-triazolo(1,5-a)pirimidina y su uso para el combate de hongos daninos.-
Inventor: OLIVER DR WAGNER
IPC: A01N43/90
Filed: 2006-07-13
Abstract: La presente invención se refiere a compuestos de 7-amino-6-triazolil-1,2,4-triazolo(1,5-a)pirimidina de la fórmula I y sus sales de tolerancia en agricultura, así como a su uso para el combate de hongos daninos, así como a agentes fitopatógenos que contienen por lo menos un compuestos de este tipo como componente eficaz.
Patent UY-30804-A1 (UY)
Title: Derivados de nicotinamida, sus sales y solvatos, composiciones farmacéuticas conteniendolas y aplicaciones
Inventor: TURNER STEVE R
IPC: A61P11/06
Filed: 2007-12-18
Abstract: La presente invencion se refiere a compuestos de formula (I) y sales y solvatos farmacéuticamente aceptables de los mismos, donde los sustituyentes son como se han definido en este documento, a composiciones que contienen tales compuestos y a los usos de tales compuestos para el tratamiento de diversas enfermedades y afecciones tales como asma.
Patent CS-8901979-A1 (CS)
Title: Method of portland clinker grinding for plasterless portland cements production
Inventor: SKVARA FRANTISEK RNDR DRSC
IPC: C04B24/12
Filed: 1989-03-30
Abstract: The invention relates to admixtures and a method for milling Portland clinker for the production of gypsumless Portland cements with specific surfaces of from 350 to 750 m<2>/kg. According to the invention, the milling is carried out in the presence of 0.01 to 0.15 mass-% of a synthetic organic surface-active substance with wetting properties which is stable in alkaline media of pH values 9 to 12.
Patent ES-182935-A1 (ES)
Title: ACUMULADOR ELÉCTRICO DE CARBoN ACTIVO Y CINC
Filed: 1948-03-13
Abstract: Acumulador eléctrico de carbón activo y cinc con electrolito de bromuro de cinc, caracterizado porque está esencialmente constituido por un aglomerado de carbón activo solo o mezclado con grafito o carbón de retorta, en proporción variable, prensado alrededor de una barra de carbón de retorta o grafito todo lo cual debidamente envuelto en un saquito de tela, papel de filtro, material poroso o vaso de materia plástica finamente taladrada o porosa constituye el electrodo positivo, el cual va sumergido en un electrolito formado por una disolución concentrada de bromuro de cinc inmovilizada o no a base de lana de vidrio, sílice o cualquiera de los materiales que usualmente se destinan a este objeto en pilas o acumuladores y como electrodo negativo sirve un vano de cinc que es a la vez receptáculo del conjunto.
Patent ES-183739-A1 (ES)
Title: Una mejora en los analizadores de electrones lentos
Filed: 1948-05-18
Abstract: Una mejora en los analizadores para tomas de visita de televisión,que utilizan la descarga de un blanco por un haz de electrodos lentos, y sujetos al defecto llamado de la "mancha blanca", caracterizada por aplicación a los electrodos del cañón de este tubo durante barrido de retorno, de tensiones tales que la energía de los electrodos del haz sea más débil que durante el barrido de ida, pero que la corriente de haz sea mucho más elevada que durante este barrido, encontrándose también ensanchada la sección de haz, siendo el defecto de este barrido de retorno al de volver todos los puntos del blanco que han recibido una iluminación excesiva a tal valor que su carga pueda neutralizarse por el haz de ida.
Patent ES-192797-A1 (ES)
Title: PERFECCIONAMIENTOS EN LOS DISPOSITIVOS DE OBSERVACIoN PROVISTOS DE MEDIOS REFREACTORES
Filed: 1950-05-03
Abstract: Perfeccionamientos en los dispositivos de observación provistos de medios refractores según los cuales dos cuerpos tubulares recíprocamente ajustados atraviesan las superficies de su instalación y permanecen solidarizados a unas coronas contando uno de ellos con dos cámaras interiores una da las cuales recibe a una lenta montada sobre asientos de material elástico y otra en la que se encuentran dispuestos con cierta inclinación pero paralelos entre sí unos elementos refractores que trasladan las imágenes que reciben hasta el punto de observación.
Patent ES-197210-A1 (ES)
Title: UN PROCEDIMIENTO PARA LA PRODUCCIoN DE SIMIENTES TRIPLOIDES REMOLACHA AZUCARERA
Filed: 1951-03-31
Abstract: Procedimiento para la producción de simientes triploides de remolacha azúcarera mediante desfloración común de plantas disploides y tetraploides caracterizado porque una pequeña porción de plantas diploides (o tetrapolides) bien funcionales masculinamente se planta juntamente con una porción considerablemente superior de plantas tetraploides (o diploides) cuyo polén preenta un pequeño poder de fecundación o es estéril.
Patent ES-269544-A1 (ES)
Title: Process for the oxidation of cycloalkane carboxylic acid
IPC: C07C1/207
Filed: 1961-08-03
Abstract: Cycloalkanones and/or cycloalkenes and/or cycloalkenecarboxylic acids are obtained by reacting cycloalkane carboxylic acids in the liquid phase with oxygen at a temperature above 150 DEG C. in the presence of an oxidation catalyst comprising one or more metal compounds at least in part dissolved in the reaction liquid. The cycloalkanone and cycloalkene can be recovered by distillation. Water and/or water vapour promote the reaction and inhibit ester formation. The catalyst preferably comprises one or more copper compounds, e.g. an oxide or salt, the copper salt of the cycloalkane carboxylic acid being preferred. Magnesium and silver oxides and salts are also suitable. Copper compounds may be used together with a compound of another metal such as an alkali metal or alkaline earth metal, magnesium or barium or a heavy metal such as manganese. The cycloalkane carboxylic acid may be dissolved in water or an inert solvent or may be used in the form of a melt. Examples describe oxidation of cyclohexane carboxylic acid and cyclopentane carboxylic acid.ALSO:Cycloalkenes are obtained with cycloalkanones and/or cycloalkenecarboxylic acids by reacting cycloalkane carboxylic acids in the liquid phase with oxygen at a temperature above 150 DEG C. in the presence of an oxidation catalyst comprising one or more metal compounds at least in part dissolved in the reaction liquid. The cycloalkene can be recovered by distillation. Water and/or water vapour promote the reaction and inhibit ester formation. The preferred catalyst comprises one or more copper compounds, e.g. an oxide or salt, the copper salt of the cycloalkane carboxylic acid being preferred. Magnesium and silver oxides and salts are also suitable. Copper compounds may be used together with a compound of another metal such as an alkali metal or alkaline earth metal, magnesium or barium or a heavy metal such as manganese. The cycloalkane carboxylic acid may be dissolved in water or an inert solvent or may be used in the form of a melt. Examples describe oxidation of cyclohexane carboxylic acid and cyclopentane carboxylic acid.
Patent ES-274879-A1 (ES)
Title: Filamentary material
IPC: D06P3/00
Filed: 1962-02-23
Abstract: Shaped articles made from solid oxymethylene polymers are dyed The polymer may contain units having consequential carbon atoms, e.g. dioxolane or ethylene oxide comonomers. Stabilizers, e.g. 2,21-methylene-bis-(4-methyl-6-t. -butylphenol) and malonamide or cyanoguanidine may be present. Specified dyes are the azo, anthraquinone and acetate dyes.ALSO:Shaped articles made from solid oxymethylene polymers are dyed by maintaining the article in contact with an aqueous dispersion of a disperse dyestuff at an elevated temperature until the article assumes the desired depth of colour the dyebath may contain from 0.01 to 10% of dyestuff, based on the article weight, and may be maintained at 80 to 95 DEG C. and the article kept in contact within this hot dyebath for 30 minutes to 4 hours. Specified dyes are azo dyes, anthraquinone dyes and acetate dyes. The article may be scoured before dyeing. Specified articles are tow, yarn, roving, sliver, batting or knitted or woven textile fabric and also films. In examples (1) a filamentary material from a trioxane-dioxolane copolymer is dyed by immersion in a simulated infinite dyebath containing Eastone Red NGLF in water at 97 DEG C. for 1 hour and (2) ladies stockings from an oxymethylene polymer containing 2% ethylene oxide units is dyed in a bath of "Celliton" (Registered Trade Mark) Brown 3-RA, Eastman Blue BNN, sodium N-methyl-N-oleyl laurate, Calgon, orthophenylphenol and water for 30 minutes at 95 DEG C.
Patent ES-289494-A1 (ES)
Title: Process for producing sodium cyanide
IPC: C01C3/10
Filed: 1963-06-28
Abstract: A process of preparing sodium cyanide dihydrate crystals comprises preparing an aqueous solution containing less than 820 g./l. NaCN by substantially neutralizing with hydrogen cyanide an unsaturated sodium cyanide solution, to which sodium hydroxide has been added, cooling the resultant solution to saturate and then supersaturate it within the zone defined by its saturation and supersaturation curves, and adding NaCN.2H2O seed crystals to the supersaturated solution in order to form larger crystals of NaCN.2H2O. The NaOH content of the unsaturated sodium cyanide solution may be between 30 and 100 g./l. An excess of 0.2 to 3.0% by wt. NaOH may be present after neutralization with hydrogen cyanide, which may be added in the liquid form. The solution to be neutralized by hydrogen cyanide may be formed by adding mother liquors of the crystallization step to a sodium hydroxide solution having a concentration corresponding to NaOH.H2O. In an example, NaCN mother liquors from a crystallizer-decanter are mixed with a hot aqueous NaOH solution corresponding to NaOH.H2O, cooled, injected through a Venturi tube wherein it is mixed with liquid HCN which is added at a rate regulated by the sodium hydroxide flow. The resultant solution is pumped to a heat exchanger wherein it is cooled to the desired supersaturation state. The supersaturated solution is introduced into the lower part of the crystallizer-decanter together with NaCN.2H2O seed crystals. Large crystals are extracted from the bottom of the decenter. Specification 230,423 is referred to.
Patent ES-298197-A1 (ES)
Title: Improvements in or relating to the inhibition of caking of hexamethylenetetramine
IPC: B01J2/30
Filed: 1964-03-31
Abstract: The caking tendency of hexamethylenetetramine is inhibited by admixing therewith a mixture comprising (A) diatomaceous earth, or stearic acid, or calcium or magnesium stearate, with (B) benzoic acid, said mixture being used in a proportion of from 0.5 to 1% by weight of the hexamethylenetetramine, and the weight ratio of (A) to (B) being in the range of 5 to 1 to 10 to 1, the component (A) being used for preference in a substantially anhydrous form. It is preferred that the hexamethylenetetramine contains no more than 1% of water. The description includes details of the test for comparing the inhibition of the caking tendency and gives details of particle sizes of the various components. The examples include data of the effect of the single components forming the inhibitors for comparative purposes, to illustrate the synergistic effect on each other and further data is provided on the effect of water content of the inhibitor and hexamine itself.
Patent ES-313130-A1 (ES)
Title: Thermal power installations utilizing liquefied natural gas
IPC: F02C7/143
Filed: 1965-05-19
Abstract: The invention relates to a closed cycle gas turbine plant in which the gas in the closed cycle is cooled before admission to the compressor by heat exchange with liquefied natural gas, the liquefied natural gas being thereby changed back to the gaseous state. In the plant shown the working fluid of the closed cycle plant is helium which is first cooled in a pre-cooler 5 and then compressed in a compressor 1. The helium under pressure is then heated in a heater 6 and then further heated in a heater 7 before passing into a turbine 2 which drives the compressor 1. The helium is then further expanded in a second, useful power turbine 3 which drives an electric generator 4. The helium discharging from the turbine 3 is cooled in the heat exchanger 6 and then further cooled in the pre-cooler 5. Liquefied natural gas from the reservoir 8 is delivered by pump 10 through the heat exchanger 5 wherein the liquefied natural gas is heated and changed back to the gaseous state and the helium in the closed circuit is cooled. The natural gas in the gaseous state is supplied to a gas line. A portion of the natural gas in the gaseous state passes to the combustion chamber 9, the combustion products from which pass through the heat exchanger 7 to heat the helium before admission to the turbine 7.